Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Connective Therapeutics reports progress on interferon gamma

Dec. 20, 1996

Carrington Laboratories and Recordati reach licensing agreement

Dec. 19, 1996

New alopecia Rx tested in patients

Dec. 18, 1996

Piliel enters pivotal trials in Europe

Dec. 18, 1996

Protein Polymer Technologies and Ethicon extend R&D collaboration

Dec. 17, 1996

Glaxo Wellcome granted license to Cellegy orphan drug

Dec. 16, 1996

Advanced Polymer Systems to supply Johnson & Johnson with Microsponge-entrapped AHAs

Dec. 16, 1996

First marketing approval for Allergan antipsoriatic

Dec. 13, 1996

Vertex selects lead development candidate for autoimmune diseases

Dec. 13, 1996

hu1124 advances to clinical studies

Dec. 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.